Publication | Closed Access

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4+ T cells in the broncho-alveolar lavage of patients with systemic sclerosis

Imatinib ResultsAllergyAutoimmune DiseaseSclerodermaSystemic SclerodermaT-regulatory CellImmunologyPulmonary Alveolar ProteinosisSystemic SclerosisAutoimmunityImmunologic DiseaseBroncho-alveolar LavageImmunotherapyMedicine